Jacqueline Ray+FollowCDC Vaccine Report Cites a Phantom Study?!Did you see this? The CDC’s vaccine committee is about to discuss a report that references a study… that doesn’t even exist! The scientist supposedly behind it says he never did that research, and his actual study came to totally different conclusions. This all comes as the panel was just overhauled with several anti-vaccine voices, sparking calls from both parties to delay the meeting. The drama around thimerosal in vaccines is getting wild! #VaccineNews #CDC #Thimerosal #Health20Share
rmartinFollowing‘Razor Blade Throat’ COVID Is Back?!Have you heard about this new COVID subvariant, Nimbus? It’s taking over California and people are saying it feels like you swallowed razor blades—ouch. Wastewater and test numbers are creeping up, but hospitals aren’t packed yet. Meanwhile, there’s drama over vaccine policies: top CDC vaccine advisors just got fired, and experts are worried this could mess with access to shots for everyone, especially pregnant women and kids. Wild times for public health! #COVID19 #NimbusVariant #VaccineNews #Health #BodyHealth5433Share
Chris Lyons+FollowOxford’s Racing to Stop the Next PandemicA vaccine for the super-deadly Nipah virus (think: up to 85% fatality rate!) just got a major fast-track from European regulators. Oxford’s working on it after some promising early results, and the World Health Organization is watching closely since Nipah could spark the next big pandemic. It spreads from animals, food, or even person-to-person—yikes. Fingers crossed this jab gets out there before Nipah does! #NipahVirus #VaccineNews #OxfordUniversity #Health50Share
Ryan Lewis+FollowBreast Cancer Vaccine Breakthrough?!A breast cancer vaccine just wrapped up its first trial and get this—over 75% of women showed a strong immune response! This could be a total game-changer for the most common (and deadliest) cancer in women. The vaccine targets a protein only found in breast cancer cells, so it’s super specific. Next up: bigger trials, but researchers are hyped that this could actually wipe out breast cancer, like we did with polio. Imagine a world without breast cancer! #BreastCancerAwareness #MedicalBreakthrough #VaccineNews #Health49546Share
Spencer Brewer+FollowModerna’s New Vax Gets Green Light!Moderna just scored FDA approval for its next-gen COVID-19 shot, mNEXSPIKE—even with all the investor drama and rumors flying around. This new vax is for adults 65+ and anyone 12-64 with health risks, and it’s got some cool upgrades: lower dose, longer shelf life, and easier storage than Spikevax. Despite all the chatter about changing vaccine guidelines, the CDC still recommends COVID shots for healthy kids (if parents/doctors agree). Big pharma drama, but Moderna’s moving forward! #Moderna #COVID19 #VaccineNews #Health10Share
elizabethwang+FollowPregnant? Kids? Big COVID Vax News DropMajor shakeup: The feds just stopped recommending COVID vaccines for healthy pregnant people and kids, and experts are NOT happy. Docs say the science hasn’t changed—COVID is still risky for pregnant folks and little ones, and the vax is proven safe. Now, insurance coverage and access could get messy, and families might lose the choice to vaccinate. Plus, this move skipped the usual expert review, so legal battles are likely. Wild times for vaccine policy! #COVID19 #VaccineNews #PregnancyHealth #Health72Share
Christian Boone+FollowModerna Drops a New COVID Shot—But There’s a CatchModerna just got FDA approval for a new COVID-19 vaccine, mNexspike, but it’s not for everyone. This next-gen shot uses a much lower dose and is only for adults 65+ or people 12-64 with health risks. It’s not replacing the old vax—just adding another option. The twist? These limits are new for the U.S., and some say it’s politics, not science, driving the change. What do you think: smart move or too cautious? #COVID19 #Moderna #VaccineNews #Health925Share
peterfoster+FollowWhy the Feds Just Ghosted ModernaHeads up: The government just pulled the plug on a $766 million deal with Moderna for a bird flu vaccine. Translation? No more big bucks for Moderna’s new shot, even though early tests looked good. The reason: officials want to back tried-and-true vaccine methods, not just the latest tech. If you’re counting on quick shots in a future outbreak, this could mean fewer options—and maybe longer waits. Stay tuned for what Moderna does next! #VaccineNews #Moderna #BirdFlu #Business2511Share
Melanie James+FollowFDA Narrows COVID Vax—Who’s Still Eligible?Big shift: The FDA just announced that only adults 65+ and people with certain health risks (think asthma, cancer, diabetes, etc.) will be able to get the new COVID-19 vaccine this fall. Healthy younger adults and kids? Not on the list unless new trials prove it’s worth it. This move is sparking debate—some say it’s about safety, others worry it’ll make vaccines harder to get and fuel more hesitancy. What do you think about this new approach? #COVID19 #VaccineUpdate #FDA #PublicHealth #VaccineNews #Health20Share
Spencer Brewer+FollowModerna’s Combo Vax Hits a RoadblockModerna just yanked its FDA application for their much-hyped combo flu/COVID shot, even after saying it worked better than current vaccines. Turns out, the FDA wants more data, so Moderna’s pushing approval back to 2026 and deprioritizing the shot for now. Their stock dropped 4.5% on the news. They’ll try again later this year when more trial results come in. Meanwhile, the FDA’s getting stricter on vaccine approvals, and Pfizer’s racing ahead with its own combo vax. Wild times in vaccine land! #Moderna #VaccineNews #Biotech #FDA #COVID19 #Health10Share
